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ABSTRACT
Background
Large state tobacco control programs have been shown to reduce smoking and would be
expected to affect health care costs. We investigate the effect of California’s large-scale tobacco
control program on aggregate personal health care expenditures in the state.
Methods and Findings
Cointegrating regressions were used to predict (1) the difference in per capita cigarette
consumption between California and 38 control states as a function of the difference in
cumulative expenditures of the California and control state tobacco control programs, and (2)
the relationship between the difference in cigarette consumption and the difference in per
capita personal health expenditures between the control states and California between 1980
and 2004. Between 1989 (when it started) and 2004, the California program was associated with
$86 billion (2004 US dollars) (95% confidence interval [CI] $28 billion to $151 billion) lower
health care expenditures than would have been expected without the program. This reduction
grew over time, reaching 7.3% (95% CI 2.7%–12.1%) of total health care expenditures in 2004.
Conclusions
A strong tobacco control program is not only associated with reduced smoking, but also with
reductions in health care expenditures.
The Editors’ Summary of this article follows the references.
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Large-scale tobacco control programs reduce cigarette
consumption [1,2] and tobacco-induced heart disease [3] and
cancer [4–6]. Despite the availability of large amounts of
money from state tobacco taxes and legal settlements with the
tobacco industry, little of this money has been invested in
tobacco control programs [7,8]. Rapidly increasing health
care expenditures are a major problem in the United States
and around the world. Increased state and United States
health care expenditures have been linked with smoking [9–
11], and would be expected to diminish with reduced
smoking, but there has been no direct estimate of the effects
of large-scale tobacco control programs on health care
expenditures.
The California Tobacco Control Program (CTCP), estab-
lished in 1989 [12–15], has adopted a comprehensive
approach designed to change social norms rather than a
frontal attack designed to market cessation services directly
to tobacco users. According to key planning documents for
the program, this ‘‘social norm change’’ approach seeks ‘‘to
indirectly inﬂuence current and potential future tobacco
users by creating a social milieu and legal climate in which
tobacco becomes less desirable, less acceptable, and less
accessible’’ [13]. The campaign has combined an aggressive
media campaign with three consistent themes—the tobacco
industry lies, nicotine is addictive, and secondhand smoke
kills [15]—with public policy change, particularly in the area
of promoting smoke-free environments. The program differs
from many others in that it is focused on adults and social
norm change, rather than on adolescent tobacco use
prevention, because ‘‘in keeping with the social norm change
model, the ‘next generation’ cannot be saved without
changing the generations who have already reached adult-
hood’’ [13]. The program has been premised on the fact that
youth smoking will decline when more adults stop smoking
[13]. The program has been functioning continuously at
varying levels of intensity since then, which permitted us to
investigate the effect of California’s large-scale state tobacco
control program on aggregate personal health care expendi-
tures in the state.
The determinants of health care expenditures are not a
statistically stationary process (i.e., one whose underlying
determinants are constant over time) because of changes in
medical technology, population mix, and many other
variables. Engle and Granger [16] developed the approach
of cointegrating regressions that can address this issue, and
that describes long-run relationships between nonstationary
economic variables over time [17]. We model the relation-
ships between per capita tobacco control expenditures, per
capita cigarette consumption, and health care expenditures
as a system of two cointegrating regressions to model the
long-run relationships and associated equilibrium correction
regressions to model short-run relationships [18–20], to assess
whether a large-scale tobacco control program is associated
with a detectable drop in health care expenditures.
Methods
Design
This study used regression analysis of aggregate time series
data between 1980 and 2004 on smoking, health care
expenditures, and exposure to a tobacco control educational
program, in California and a control group of 38 states, to
assess the effect of the program on total personal health care
spending. The control states were selected because they did
not have signiﬁcant comprehensive tobacco control pro-
grams before ﬁscal year 2000 or cigarette tax increases of
$0.50 or more per pack over the study period [21] (Alabama,
Arkansas, Colorado, Connecticut, Delaware, Georgia, Idaho,
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine,
Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada,
New Hampshire, New Mexico, North Carolina, North Dakota,
Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina,
South Dakota, Tennessee, Texas, Utah, Vermont, Virginia,
West Virginia, Wisconsin, and Wyoming). Total personal
health care spending consists of hospital care, physician
services, other professional services, dental services, pre-
scription drugs, other health nondurables, vision products
and other health durables, home health care, nursing home
care, and other personal health care.
Annual per capita all-payer total health care expenditures
in California were modeled as a function of corresponding
heath care expenditures in the control states and the
difference in annual per capita cigarette consumption
between California and the control states. This speciﬁcation
controlled for common national trends in per capita health
care expenditures and smoking over time (e.g., trends in
medical practice, insurance status, access to care, medical
cost inﬂation, demographic changes):
hCA;t ¼ a0 þ a1hcontrol;t þ a2ðscontrol;t   sCA;tÞþt1;t ð1Þ
where
hi,t ¼ per capita real total all-payer health care expendi-
tures in i (California or control states) in year t in
2004 US dollars,
si,t ¼ per capita cigarette consumption in i in year t in 2004
US dollars,
t1,t ¼ stationary residual for year t in Equation 1.
t ¼ year (t0 ¼ 1980 to t25 ¼ 2004).
The difference between California and control states’ per
capita cigarette consumption was modeled as a function of
the difference in cumulative per capita California and control
state tobacco control expenditures and cigarette prices.
Cumulative expenditures were used because some types of
expenditures in any given year (e.g., training, community
mobilization to effect policy change) are unlikely to change
cigarette consumption immediately but will affect it over a
longer period and expenditures for speciﬁc programs and
services (e.g., media interventions, quit lines) may affect
consumption several years later, because successful cessation
is a process that usually takes many years and multiple quit
attempts, and cohorts of youth with decreased initiation rates
will slowly enter the population [22]. Thus, we obtain
ðscontrol;t   sCA;tÞ¼b0 þ b1ðECA;t   Econtrol;tÞþb2pCA;t
þ b3pcontrol;t þ b4ðt   t0Þþt2;t ð2Þ
where
Ei,t ¼ cumulative real annual per capita tobacco control
expenditures in i (California or the control states)
in 2004 US dollars,
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during year t in 2004 US dollars,
(t   t0) ¼ time, t, elapsed since t0 ¼ 1980, in years,
t2,t ¼ stationary residual for year t in Equation 2.
The linear deterministic trend was included in Equation 2
because a preliminary speciﬁcation without it produced
ambiguous results for unit root tests for stationarity of the
cointegrating regression residuals, suggesting the need to
include a linear deterministic trend.
These two equations form a recursive system in which
tobacco control spending does not directly affect health care
spending in the structural relationships. A single reduced
form equation could be estimated by substituting the differ-
ence in cigarette consumption (scontrol,t sCA,t) out of Equation
1. However, this speciﬁcation would produce more compli-
cated error terms and severely reduce the degrees of freedom
for estimation, so estimation of the structural equations is
preferred in this case.
The short-run behavior of variables in a cointegrating
relationship is described the by equilibrium correction model
(ECM) equations [16,18–20] and at least one ECM equation
must exist for each cointegrating regression in the structural
system. In this model the ECM equations are
DhCA;t ¼ c1t1;t 1 þ c2DhCA;t 1 þ e1;t ð3Þ
where
DhCA,t ¼ ﬁrst difference of California annual per capita
health care expenditures,
t1,t 1 ¼ lagged residual from Equation 1,
e1,t ¼ normally distributed independent residual,
Dðscontrol;t   sCA;tÞ¼g0 þ g1t2;t 1 þ g2Dðscontrol;t 1   sCA;t 1Þ
þ e2;t ð4Þ
where
D(scontrol,t sCA,t) ¼ ﬁrst difference of California and controls
state cigarette consumption at time t,
t2,t 1 ¼ lagged error from cointegration Equa-
tion 2,
e2,t ¼ normally distributed independent resid-
ual.
The coefﬁcient g0 quantiﬁes drift in D(scontrol,t   sCA,t); c1,g1
are the equilibrium (or error) correction terms that quantify
the short-run response of the dependent variable to the
lagged cointegrating regression residuals, t1,t 1, t2,t 1, that
describe departures from the long-run relationship described
by the cointegrating regressions (Equations 1 and 2)
respectively.
Text S1 details the regression methods to estimate the
parameters in these equations.
Data Sources (Table S1)
Annual calendar-year health expenditure data by state of
all-payer (1980–2004) and resident (1991–1998) were ob-
tained from Centers for Medicare and Medicaid Services [23]
and normalized to 2004 US dollars using the Bureau of the
Census resident population intercensal July estimates by state
and year [24,25] and the Bureau of Labor Statistics’ regional
and metropolitan area all-item Consumer Price Index (CPI)
and Medical Care Consumer Price Index (MCPI) for all urban
consumers [26]. Cigarette consumption data and sales-
weighted average cost per pack for ﬁscal year (July–June)
were obtained from the Tax Burden on Tobacco [27] and
adjusted to 2004 values using the all-item CPI [26].
Population-weighted averages for health care expenditures,
per capita cigarette consumption, and price were calculated
for the control states using their regional MCPIs, except in
the West, where we used a non-California West region MCPI
calculated using population weighted California and West
region MCPIs [26].
The real annual per capita tobacco control expenditures
were obtained for California from the Tobacco Tax Surtax
Fund Health Education Account to the California Depart-
ment of Health Services Tobacco Control Section and
California Department of Education [28] by ﬁscal year and
from Farrelly [22] for the average values for the 38 control
states, including state funding and funds from the Centers
from Disease Control and Prevention and (during the 1990s)
the National Cancer Institute ASSIST program [29]. (Cal-
ifornia did not receive CDC or ASSIST funds.)
Model Reliability and Sensitivity Analyses
We performed a wide range of tests of model reliability and
sensitivity analysis (detailed in Text S1) to ensure that our
results were not an artifact of the way the model was
formulated or a result of variables that were left out of the
model. The focus of these supplementary analyses was to
eliminate the possibility that some concurrent process
produced the observed differences between California and
the control states, for example, earlier and more extensive
penetration of managed care in California than in the control
states. These analyses included (1) in-sample dynamic
predictions of California health expenditure (Equations 1
and 3) and difference in per capita cigarette consumption
(Equations 2 and 4); (2) sensitivity analysis of results to choice
of controls and price deﬂators for California health expendi-
tures (Equation 1); (3) out-of-sample forecasts of the depend-
ent (endogenous) variables to check stability of estimated
parameters for Equations 1 and 2; (4) reverse regression of
cointegrating regressions (Equations 1 and 2); (5) time series
modeling of possible untaxed cigarette consumption in
California (Equation 1); (6) recursive estimates of the
regression coefﬁcients to check model stability over time
for Equations 1 and 2; (7) sensitivity analysis of the exogenous
time trends; and (8) unrestricted estimation of the effect of
changes in per capita cigarette consumption on California
health care expenditures in Equation 1.
Additional sensitivity analyses (see Text S1) were performed
to determine the robustness of the estimated relationship to
alternative estimators; sensitivity analysis of results to
inclusion of measures of differences between California and
controls, including prevalence of behavioral risk factors
(overweight, obesity, hypertension, binge drinking, no regular
exercise), demographic factors (white race, Hispanic ethnic-
ity), age structure, health industry structure (cost structure of
health care inputs, California versus US managed care
penetration, active [licensed] physicians per capita, hospital
beds per capita, proportion of population receiving Medicaid
services), and economic activity (per capita real personal
income) for Equations 1 or 2, or both, as appropriate;
alternative time aggregation using calendar and both calendar
and ﬁscal year data; and estimates of stationary distributed lag
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analyses materially affected the results.
Estimation of Aggregate Effects on California Cigarette
Consumption and Health Care Costs
To estimate the aggregate effect of the CTCP on cigarette
consumption and total personal health expenditures, we used
the parameter estimates and associated standard errors (SEs)
in Table 1 from the cointegrating and ECM regressions
(Equations 1–4) to construct 10,000 Monte Carlo simulations
of cigarette consumption and health care expenditure
differences between California and control states with the
actual tobacco control program expenditures and with those
expenditures set to zero (using the R 2.6.1 [30] statistical
software package). The dependent variables in the simula-
tions were initialized with observed values of personal health
care expenditures in California and the control states,
observed difference in annual cigarette consumption be-
tween California and the control states, cumulative tobacco
control expenditure data, and annual cigarette price data for
ﬁscal years 1980–1983. Per capita results were multiplied by
the population of California and adjusted to 2004 US dollars
using the MCPI for health care costs and the CPI for cigarette
costs.
To evaluate the effects of declining funding for the CTCP,
we repeated the estimations assuming that the CTCP was
funded at the same per capita level as the average of the ﬁrst 3
y of the program ($4.76 per capita in 2004 US dollars).
Results
Estimates and Hypothesis Tests
Both per capita health expenditures in the control states
and the difference in per capita cigarette consumption
between the control states and California are highly
signiﬁcant predictors of California per capita health care
expenditures and ﬁt the data well (Figure 1; Table 1). An
increase of one pack per capita per annum consumption of
cigarettes is estimated to increase per capita health care costs
by $27.00 (SE $1.82).
Both average California and control cigarette prices have a
signiﬁcant effect on the difference in cigarette consumption
Table 1. Estimated California Personal Health Expenditure and Per Capita Cigarette Consumption
Dependent Variable Equation Results nR
2 RMSE Autocor-
relation
California per capita personal
health care expenditures (2004$)
Cointegrating
regression
hCA,t ¼ $2,736 (6 $173) þ 0.599 (6 0.0519) hcontrol,t
  $27.00 (6 $1.82)(/pack per capita)( scontrol,t   sCA,t)
þ t1,t
25 0.91 46.0 0.09
Equilibrium correction
model
DhCA,t ¼  0.759 (6 0.390) t1,t 1
þ 0.481 (6 0.221) DhCA,t 1 þ e1,t
23 0.21 71.9 0.11
Difference in cigarette consumption
in California and control states
(packs per capita)
Cointegrating
regression
(scontrol,t   sCA,t) ¼ 30.3 (6 2.15) þ 0.261 (6 0.0780) (packs per capita)/
($ per capita)( ECA,t   Econtrol,t) þ 11.3 (6 2.20)
(packs per capita)/($ per pack) pCA,t   22.6 (6 2.90)
(packs per capita)/($ per pack)pcontrol,t þ 1.69 (6 0.187)
(packs per capita/year)( t   1980) þ t2,t
25 0.98 1.75  0.23
a
Equilibrium correction
model
D(scontrol,t   sCA,t) ¼ 0.946 (6 0.404)   0.960 (6 0.232) t2,t 1
þ 0.315 (6 0.185) D(scontrol,t 1   sCA,t 1) þ e2,t
23 0.46 1.57  0.04
Parameter estimates (6 standard errors).
hi,t, annual per capita health care expenditures in year t (2004$).
si,t, annual cigarette consumption (packs per capita).
Ei,t, cumulative tobacco control program expenditures in i (California or control states) through year t (2004$).
Autocorrelation: first order autocorrelation coefficient of ACF.
aStatistically significant auto-correlation in residuals at 5% significance level, Box-Ljung Q test, which appear to constitute moving average process at 2nd and 3rd lag.
doi:10.1371/journal.pmed.0050178.t001
Figure 1. California Personal Health Care Expenditures and Difference in
Cigarette Consumption between Control States and California
Endogenous variables per capita California personal health care
expenditures hCA,t (top graph), and difference in per capita cigarette
consumption between the control states and California, (scontrol,t   sCA,t)
(bottom graph), are generated from the estimated model equations and
observed exogenous variables using dynamic predictions, and follow the
observed values (dots) of the dependent variables closely. The dotted
lines are the predicted long-run cointegrating relationships (Equations 1
and 3) and the solid lines add the short-run fluctuations from the ECM
(Equations 2 and 4) to the long-run predictions.
doi:10.1371/journal.pmed.0050178.g001
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Table 1), and are consistent with the interpretation of
Equation 2 as a demand relationship. An increase of $1.00
in cumulative per capita California tobacco control expendi-
tures over that in control states was associated with a decrease
in per capita cigarette consumption of 0.261 (SE 0.078) packs
per capita compared to control states. The price coefﬁcients
imply moving average arc long-run price elasticities of
demand between 0.30–0.45 (control) and 0.30–0.70 (Califor-
nia) before 1998. Elasticities for both groups increased
rapidly after the substantial price increases beginning in
1999 to approximately unity.
The estimated error terms for both Equations 1 and 2 were
stationary, indicating that the estimated equations were
cointegrating and that statistical inference on the parameter
estimates is valid. The estimated error terms for Equation 1
were normally distributed and there were no apparent
outliers or serial correlation, but this was not the case for
Equation 2. Therefore, alternative estimators were used for
Equation 2 that provided robust parameter estimates; these
did not change the results signiﬁcantly.
The error correction terms in terms of in both ECM
equations (c1 and g1) are signiﬁcant and just below  1,
indicating rapid adjustment to the long-run equilibrium
values. Parameter estimates in the ECM equations were less
certain due to small sample size and square root of sample
size convergence of coefﬁcient estimates with stationary
variables. The estimates of the ECM model (Table 1) were well
behaved for the cointegrating regression for health care
expenditure (Equation 1) and had uncorrelated normally
distributed residuals. The ECM residuals for Equation 2 were
non-normal because of several outliers, two of which were
inﬂuential. The parameter estimates for Equation 2 did not
change signiﬁcantly with the use of robust estimation
techniques such as quantile regression and Huber robust
regressions or deletion of the effect of the observations
causing the outliers.
Cumulative Effect of the California Tobacco Control
Program
The estimated total savings in personal health care
expenditure between the start of the CTCP in ﬁscal year
(FY) 1989–1990 and FY2003–2004 is $86 billion (2004 US
dollars) (95% CI $28 billion to $151 billion) and generally
grew over time (Figures 2 and 3), reaching 7.3% of the total in
FY2003–2004, after the program had been running for 15 y.
This $86 billion in reduced health care costs represents about
a 50-fold return on the $1.8 billion (in 2004 US dollars) spent
on the CTCP during the same period.
The CTCP was also associated with 3.6 billion (95% CI 1.5
billion to 5.9 billion) fewer packs of cigarettes being sold
between FY 1989–1990 and FY 2003–2004 than would be
predicted without the program (Figure 2 bottom), represent-
ing a loss to the tobacco industry of $9.2 billion (95% CI $3.8
billion to $14.7 billion) in 2004 US dollars in pre-tax cigarette
sales.
The CTCP experienced substantial diversions of funding,
particularly in the mid-1990s [31], and the available funds are
losing purchasing power due to inﬂation because it is funded
with a constant tax of $0.05 per pack. Had the program been
maintained at the same level of purchasing power as it had
during the ﬁrst 3 y of the program (averaging $4.76 per capita
Figure 2. Effect of California Tobacco Control Program on Personal
Health Care Expenditures and Cigarette Consumption
The observed (dots) and predicted personal health care expenditures
(top graph) and difference in cigarette consumption between the control
states and California (bottom graph) with (darker lines) and without
(lighter lines) tobacco control expenditures show that the program had a
substantial effect on both variables. The dynamic predictions of per
capita California health care expenditure, hCA,t, uses predicted values for
difference in cigarette consumption, (scontrol,t   sCA,t), that are generated
by dynamic predictions using Equations 1–4. The endogenous variables
hCA,t and (scontrol,t sCA,t) are generated from the estimated equations and
observed exogenous variables for these dynamic predictions. In this
figure the prediction for California health care expenditure uses
predicted difference in cigarette consumption from Equations 2 and 4
as an explanatory variable rather than observed (as it was in Figure 1, top
graph), which increases the prediction error in this more vigorous test of
the model. The vertical differences between the darker and lighter solid
lines show the effect of the CTCP expenditures.
doi:10.1371/journal.pmed.0050178.g002
Figure 3. Savings in Personal Health Care Expenditures
The estimated annual personal health care expenditures savings
associated with the CTCP began to appear shortly after the program
began and grew over time. (Lighter lines indicate the 95% CI for the
annual savings.)
doi:10.1371/journal.pmed.0050178.g003
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the US Centers for Disease Control and Prevention [CDC]
recommends for California [2]), we estimate that the total
savings in personal health expenditures would have increased
to $156 billion (95% CI $52 billion to $267 billion), an
additional $70 billion in health cost savings. This scenario
would have required providing an additional $1.2 billion over
the 15-y period, about $80 million a year in additional funds
in 2004 US dollars, to obtain an additional $70 billion in
health care cost savings.) At the same time, this higher level of
funding for tobacco control would have increased the drop in
cigarette consumption to 6.6 billion packs (95% CI 2.7 billion
to 10.6 billion), with a corresponding loss in pretax revenue
to the tobacco industry of $16.7 billion 2004 US dollars (95%
CI $7.0 billion to $26.9 billion).
Discussion
Our estimates conﬁrm earlier work demonstrating that the
CTCP has reduced smoking in California relative to other
states, and demonstrate, for the ﬁrst time, that these
reductions are associated with substantial, rapid, and growing
reductions in per capita state health care expenditures. The
medical expenditure savings begin to appear quickly and
grow over time and are about 50 times the expenditures of
the CTCP.
Comparisons with Other Cost Estimates of Smoking
The range of cigarette price elasticities we observed prior
to 1999 is consistent with previous estimates of long-run
elasticities using panel data and generalized methods of
moments estimates [32,33]. (The authors are not aware of a
substantial literature on the response of elasticity after the
price increases immediately preceding the year 2000, so it was
not possible to evaluate the implied elasticities for this
period.) The coefﬁcient of the deterministic time trend of
1.69 packs per capita per year (SE 0.187) suggests a long-run
divergence of California and control states per capita
cigarette consumption, holding other factors constant (in-
cluding the effect of the CTCP).
The cost estimate of the annual reduction in per capita
health care costs of $27.00 per pack per capita consumed
seems very high if inappropriately interpreted to be the cost
of each pack consumed by current smokers. The CDC
estimated an excess health care cost per active smoker of
$3,036 annually (in 2004 US dollars) [11]. Per capita
consumption in the US during 2004 was 90.7 packs [34] and
smoking prevalence was 20.4% (SE 0.3% computed using the
delta method) [35], which implies direct health costs of $6.88
(SE $0.11) per pack, consistent with previous estimates
[10,36]. The regression estimates presented here model the
difference between California and control state costs; there-
fore, the difference between per capita cigarette consump-
tion is the appropriate number to use to convert from per
pack to per capita costs. Using our data over the observation
period, the mean difference between California and average
control state consumption was 34.3 packs per capita, mean
California smoking prevalence in 1992–1993 was 19.4% (SE
0.3%), and mean control state prevalence for the same years
was 23.9% (SE 0.1%) [37]. Therefore, the base case control
state estimate of $27.00 (SE $1.82) implies an annual cost of
smoking per capita of $27.00/(pack per capita) 3 34.3 packs
per capita ¼ $926, and a cost per smoker of between $926/
0.239 ¼ $3,940 (SE $266) and $926/0.194 ¼ $4,800 (SE $330).
Existing estimates of the cost of smoking per pack and per
smoker referenced above are probably too low, because they
omit (1) recently discovered health effects of smoking (for
example, several vision impairments, periodontal disease,
colorectal cancer, and risk of dementia in old age); (2) effects
of passive smoking on older children and adolescents; and (3)
recent quasi-experimental evidence that the coronary effects
of passive smoking may be underestimated. Thus, the
estimate of the total health cost per pack of cigarettes
implied by our analysis is consistent with, and probably more
accurate than, earlier estimates based on the costs of some of
the speciﬁc smoking-related diseases. This estimate includes
health costs borne by both active and passive smokers.
Limitations
Per capita cigarette consumption is not the sole determi-
nant of risk for smoking-related disease; daily smoking status,
age at initiation, and time since cessation all affect individual
risks. While all these variables—as well as exposure to
secondhand smoke—have been affected to varying degrees
by the CTCP, we cannot disaggregate the contributions of
these different mediating variables to the observed changes.
The speciﬁcation of Equations 1 and 2 are quite simple,
therefore the possible effects of omitted variable bias is a
concern. The order of integration of potential confounding
variables helps resolve this issue in nonstationary regression.
The coefﬁcients of the cointegrating regression will not be
biased if the omitted variables are stationary [19]. Therefore
we concentrated only on potential confounders that were
nonstationary. As noted above, exploratory regression anal-
yses suggested that including any such potential confounders
for which data were available did not signiﬁcantly affect the
results. Confounding due to unobserved differences between
California health care industry and demographics is possible;
however, adjustment for differences in proportion of elderly
population, per capita income, managed care market share,
and other variables did not change our conclusions (see Text
S1).
The measure of cigarette consumption is indirect. State
warehouse removals are used as proxies for state cigarette
consumption and smoking intensity, and does not account
for sales to nonresidents and tax avoidance. If the pattern of
untaxed interstate cigarette transfers is relatively stable, then
they can be included in the analysis, but would require
disaggregated data and other statistical methods. Including
several models of untaxed cigarettes, however, did not affect
the results (see Text S1).
Implications for Future Research
The generalizability of this method using aggregate data
will depend upon availability of relatively complete and
consistent time series data and the pattern of common
statistic trends in states or countries to be compared. Where
appropriate data are available aggregate time series analysis
can be an important supplement to the use of synthetic
model-based simulation estimates that have been the princi-
pal approach in the past [38]. The use of time series analysis
allowed estimates of program effect with fewer assumptions
that are difﬁcult to verify than in these synthetic estimates.
The use of time series methods can also be used to develop
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evaluation.
The sensitivity analyses did not reveal any additional
explanatory variables that changed the coefﬁcient estimates
of the two cointegrating regressions. Other variables were
identiﬁed that appear to partially determine California and
control states per capita health care expenditure: the
proportion of population that is elderly, the managed care
market penetration rate, and the proportion of population
receiving Medicaid services. However, including these varia-
bles in Equation 1 did not affect the results signiﬁcantly, and
they appeared to form a separate cointegrating regression
relationship.
Implications for Public Policy and Tobacco Control
Program Design
It is a testament to the power of the tobacco industry [39]
that few US states or countries make substantial investments
in aggressive tobacco control programs given the rapid and
substantial beneﬁts they produce. For example, in the US,
where the states receive about $25 billion a year from the
1998 Master Settlement Agreement [7,40] that ended state
litigation against the tobacco industry and tobacco taxes, only
$720 million will be devoted to tobacco control programs in
ﬁscal year 2008 [8], well below the levels that the CDC
recommends [2]. Our results suggest that funding these
tobacco control programs at the levels that the CDC
recommends would rapidly reduce total personal heath care
expenditures by hundreds of billions of dollars.
The fact that CTCP has been focused on social norm
change among adults, not primarily on youth prevention [13],
is probably why it was associated with such rapid and large
reductions in disease and the associated health care costs. A
program focused on primary prevention of smoking among
adolescents would take decades to have any impact on
tobacco-induced diseases, which rarely manifest among
adolescents or even young adults. The rapid declines in adult
smoking and cigarette consumption explain why the program
was associated with rapid drops in heart disease [3] and
cancer [4–6] and, so, associated health care costs. This
approach also led to large reductions in youth smoking. A
program concentrated primarily on youth and primary
prevention would not have such large rapid beneﬁts.
Our results also suggest that inﬂation erodes the purchas-
ing power of a ﬁxed amount of money and calls into question
the practice of allocating a ﬁxed fraction of a ﬁxed (in
current dollar terms) excise tax on cigarettes to tobacco
control programs. The erosion of purchasing power due to
the fact that the funding for the CTCP has been at a constant
$0.05 per pack of cigarettes means that tens of billions of
dollars of likely health care expenditure savings have been
lost. When tobacco control programs are ﬁnanced by tobacco
taxes, the tax should be indexed to inﬂation to prevent this
erosion of program effectiveness over time.
Public health policy makers and advocates need to under-
stand that achieving these gains in health and reductions in
health care expenditures comes at a substantial cost to the
tobacco industry. The 3.6 billion packs of cigarettes that the
CTCP prevented from being smoked represented a loss to the
tobacco industry of $9.2 billion in pretax sales. In addition, a
key element of the program has been to confront the tobacco
industry directly [13,15] to reduce smoking initiation and
promote cessation attempts [41]. Therefore, it is not surprising
that the tobacco industry and its political allies [31] are highly
motivated to see that money is not allocated to these programs
and that what money is allocated is spent as inefﬁciently as
possible, such as by focusing efforts on young children.
Successfully realizing the potential of large-scale, aggressive
tobacco control programs will require public-health profes-
sionals to pursue advocacy strategies that are commensurate
with the opposition that these economic stakes warrant.
Conclusion
Between 1989, when it started, through 2004, the CTCP was
associated with a substantial reduction in total health costs
($86 billion in 2004 US dollars). Two of the deﬁning
characteristics of the CTCP have been its focus on the
general population (as opposed to primary prevention in
youth) and its promotion of social norm change, particularly
smoke-free environments [13]. This focus probably contrib-
uted to the substantial effect on health care expenditures,
since reductions in adult smoking lead to immediate effects
on health costs, whereas primarily prevention of youth
smoking would take decades to have any substantial effect
on health outcomes. The fact that the program reduced
pretax sales of cigarettes substantially over the same time
explains why the tobacco industry has worked so hard to roll
back the program or limit its scope to youth [31]. The $86
billion in health cost savings represents a strong return on the
public investment in the program.
While this analysis is based on California, we feel our
ﬁndings support the use of public policy interventions to
reduce tobacco consumption in other settings, and that
reductions in tobacco consumption will soon be followed
with substantial impacts on health care expenditures. Similar
results would be expected in other developed and developing
countries, with the speciﬁc amount of health care savings
depending on how expensive the medical care system is.
A strong tobacco control program can not only reduce
smoking, prevent disease, and save lives, but represents an
important way to curb rapidly increasing health care
expenditures in the short term.
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Background According to the World Health Organization (WHO),
tobacco causes 1 in 10 adult deaths worldwide and is the leading
preventable cause of death in the world. In 2005, tobacco caused 5.4
million deaths, which amounts to one death every 6 seconds. It is
estimated that by 2030, annual deaths from tobacco use will be 8 million
worldwide. Eighty percent of these deaths will occur in the developing
world.
Exposure to secondhand tobacco smoke is also a major health concern,
as it can cause cancer, heart disease, and respiratory illness. An estimated
200,000 workers die annually from exposure to smoke at work, according
to the International Labour Organization.
In 2008, the WHO released a report on the global tobacco epidemic,
which provided a comprehensive analysis of tobacco use and control
efforts. It revealed that not a single country fully implements all key
tobacco control measures. The report also stated that governments
around the world collect 500 times more money in tobacco taxes each
year than they spend on anti-tobacco efforts.
The California Tobacco Control Program (CTCP) is a state-funded public
policy intervention established in 1989. Its goal is to decrease tobacco-
related diseases and deaths in California by reducing tobacco use across
the state. The program is focused on adults and social norm change
rather than on adolescent tobacco use prevention, on the premise that
the ‘‘next generation cannot be saved without changing the generations
who have already reached adulthood.’’
Why Was This Study Done? The success of large public health
programs, especially those that counter the tactics of powerful industries
such as the tobacco industry, require funding. The justification of public
spending on these initiatives should be evidence driven. While the
success of the CTCP in reducing smoking was known, it was not yet clear
whether the program had reduced health care costs. The researchers
investigated the effect of the CTCP on personal health care expenditures
in the state. Their findings can provide useful information for the
development of other tobacco control initiatives.
What Did the Researchers Do and Find? Using the statistical approach
of cointegrating regressions, the researchers modeled the relationships
between per capita tobacco control expenditures, per capita cigarette
consumption, and health care expenditures. They analyzed data from
1980 and 2004 on smoking, health care expenditures, and exposure to a
tobacco control educational program in California and compared them
to a group of 38 control states. Control states were those without
comprehensive tobacco control programs prior to 2000 or cigarette tax
increases of $0.50 or more per pack over the study period. This
comparison allowed the researchers to assess the effect of the CTCP on
total personal health care spending.
The researchers found that US$86 billion (95% CI $28 billion to $151
billion) were saved in personal health care expenditure between 1989,
the start of the program, and 2004. This generally grew over time,
reaching 7.3% of the total in 2003–2004. The personal health care
expenditure savings represented about a 50-fold return on the $1.8
billion spent on the program during the same period (all 2004 US
dollars).
The researchers report that 3.6 billion (95% CI 1.5 billion to 5.9 billion)
fewer packs of cigarettes were sold between 1989–1990 and 2003–2004.
This represents a loss of $9.2 billion (95% CI $3.8 billion to $14.7 billion)
to the tobacco industry in pre-tax cigarette sales.
These cost savings occurred despite the substantial diversion of funding
and decreased purchasing power experienced by the CTCP, particularly
in the mid-1990s. (The program was funded with a constant tax of $0.05
per pack, despite inflation). The researchers estimated that if the funding,
and thus purchasing power, had been maintained, total savings in
personal health expenditures would have increased to $156 billion with
an additional $70 billion in health cost savings. Cigarette consumption
would have dropped to an estimated 6.6 billion packs.
What Do These Findings Mean? The CTCP has been successful in
reducing smoking in California in comparison to other states, and has
reduced personal health care expenditures. These cost reductions were
substantial, rapid, and grew over time. The researchers contend that the
CTCP’s focus on social norm change among adults, not primarily on
youth prevention, is responsible for such rapid and large reductions in
disease and the associated health care costs. They state that a program
focused on primary prevention of smoking among adolescents would
take decades to have any impact on tobacco-induced diseases, which
rarely manifest among adolescents or even young adults. These
researcher’s findings support the establishment of strong tobacco
control programs in other settings: they not only reduce smoking,
prevent disease, and save lives, but also represent an important way to
curb rapidly increasing health care expenditures in the short term.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050178.
  The California Tobacco Control Program provides information about
its social change approach
  The WHO MPOWER strategy, detailed in the 2008 Report on the Global
Tobacco Epidemic, outlines the six most effective policies to help curb
the epidemic
  Resources to help people quit smoking can be obtained through the
US Centers for Disease Control and the UK National Health Service
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